TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21865716

Group type: EXPERIMENTAL
Intervention: Nasal submucosal administration of α‐GalCer‐pulsed DCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of activated NKT cells and submucosal injection of α‐GalCer‐pulsed DCs
Number of subjects: 0
Study: 19302563

Group type: EXPERIMENTAL
Intervention: Very-low-carbohydrate diet (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mediterranean diet (Group M)
Number of subjects: 20
Study: 17503545

Group type: EXPERIMENTAL
Intervention: Structured group reminiscence therapy (8 sessions, 1 session per week)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 102
Study: 12619168

Group type: EXPERIMENTAL
Intervention: Telephone intervention (12 weeks, twice per week for first month, weekly for second and third months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 10728945

Group type: EXPERIMENTAL
Intervention: Eptifibatide regimens during intervention
Number of subjects: 4010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4010
Study: 9188113

Group type: EXPERIMENTAL
Intervention: 150 micrograms.kg‐1 ondansetron
Number of subjects: 240

Group type: COMPARATOR
Intervention: 50 micrograms.kg‐1 ondansetron
Number of subjects: 240
Study: 1540344

Group type: EXPERIMENTAL
Intervention: Autoinflation using a new device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 3886708

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine 40 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine (all doses)
Number of subjects: 10
Study: 30293410

Group type: EXPERIMENTAL
Intervention: Simple written material encouraging the benefits of physical activity (N=235)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Control group (N=311)
Number of subjects: 546
Study: 30132389

Group type: COMPARATOR
Intervention: Transcranial Direct Current Stimulation (tDCS) with anode over left dlPFC and cathode over right supraorbital region, 10 sessions of 20 minutes each.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Number of subjects: 18
Study: 26386560

Group type: COMPARATOR
Intervention: 5-FU (800 mg/m²/day, days 1-5, every 4 weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: wPTX (80 mg/m² on days 1, 8, and 15, every 4 weeks)
Number of subjects: 100
Study: 23982995

Group type: EXPERIMENTAL
Intervention: Verapamil 2.5 mg
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 1 mg
Number of subjects: 731

Group type: COMPARATOR
Intervention: Diltiazem 5 mg
Number of subjects: 731
Study: 22938031

Group type: EXPERIMENTAL
Intervention: Sliding lag screw
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-sliding lag screw
Number of subjects: 80
Study: 20478939

Group type: EXPERIMENTAL
Intervention: Suprapubic aspiration (SPA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Urine catheterization (UC)
Number of subjects: 48
Study: 18829908

Group type: EXPERIMENTAL
Intervention: Single-leg-stance radiographs (alternating right and left)
Number of subjects: 45
Study: 15753902

Group type: EXPERIMENTAL
Intervention: mUV/VIS phototherapy (UV‐B 5%, UV‐A 25%, visible light 70%)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: mUV/VIS phototherapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: low‐intensity visible light (control)
Number of subjects: 49
Study: 12324673

Group type: EXPERIMENTAL
Intervention: Self-management programme (SMP)
Number of subjects: 280
Study: 9806261

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyle starch solution (HES)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9% solution)
Number of subjects: 101
Study: 7632455

Group type: EXPERIMENTAL
Intervention: Usual advice plus individual relapse prevention counseling
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual advice from obstetrician or nurse midwife
Number of subjects: 175
Study: 2781235

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) 1.2 g/day orally for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study: 359018

Group type: EXPERIMENTAL
Intervention: Acebutolol (200-600 mg twice daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Acebutolol (once daily at optimum dose)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Acebutolol (once daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 11
Study: 30488510

Group type: EXPERIMENTAL
Intervention: HPV vaccination (3 doses)
Number of subjects: 117073

Group type: EXPERIMENTAL
Intervention: HPV vaccination (with additional information)
Number of subjects: 117073

Group type: EXPERIMENTAL
Intervention: HPV vaccination (adhering to recommended intervals)
Number of subjects: 117073
Study: 29683334

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) and posterior bite block (BB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study: 26678511

Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS)
Number of subjects: 0
Study: 24420499

Group type: EXPERIMENTAL
Intervention: Tight computerized glucose control (TGC)
Number of subjects: 2684

Group type: COMPARATOR
Intervention: Conventional glucose control (CGC)
Number of subjects: 2684
Study: 22828155

Group type: EXPERIMENTAL
Intervention: Fentanyl and propofol (group T2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol alone (group T1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol alone (group S1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl and propofol (group S2)
Number of subjects: 80
Study: 20331572

Group type: EXPERIMENTAL
Intervention: Cessation counseling during medical care
Number of subjects: 237
Study: 18200389

Group type: EXPERIMENTAL
Intervention: Dialectic‐didactic method therapy (40 sessions) for research group (RG)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group 1 (CG1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group 2 (CG2) - children with normal development (ND)
Number of subjects: 8
Study: 16025017

Group type: EXPERIMENTAL
Intervention: Enhanced digital fluoroscopic video (DFV) combined with distortion compensated roentgen analysis (DCRA)
Number of subjects: 20
Study: 11157185

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg daily for 14 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11367725

Group type: EXPERIMENTAL
Intervention: Plasma-derived hepatitis B vaccine
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 350
Study: 8106965

Group type: EXPERIMENTAL
Intervention: Foscarnet therapy
Number of subjects: 0
Study: 2557764

Group type: EXPERIMENTAL
Intervention: Cervicovaginal lavage followed by scrape‐Cytobrush
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Scrape‐Cytobrush followed by cervicovaginal lavage
Number of subjects: 74

Group type: COMPARATOR
Intervention: Scrape‐Cytobrush
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cervicovaginal lavage
Number of subjects: 74
Study: 8044721

Group type: EXPERIMENTAL
Intervention: cilazapril 2.5 mg
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: cilazapril 5 mg
Number of subjects: 130

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 130
Study: 666950

Group type: EXPERIMENTAL
Intervention: Medigoxin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 5
Study: 31970430

Group type: EXPERIMENTAL
Intervention: Posterior-stabilized (PS) TKA
Number of subjects: 34

Group type: COMPARATOR
Intervention: Anterior-stabilized (AS) TKA
Number of subjects: 34
Study: 31383027

Group type: EXPERIMENTAL
Intervention: Operative management (open reduction and internal fixation - ORIF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-operative management (humeral brace until fracture union)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Operative management (ORIF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-operative management (humeral brace)
Number of subjects: 70
Study: 28333301

Group type: EXPERIMENTAL
Intervention: Total cholesterol ≥200 mg/dl
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Abnormal lipoprotein levels
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Low HDL-C <50 mg/dl
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Elevated triglycerides ≥150 mg/dl
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Elevated LDL-C ≥130 mg/dl
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Elevated total cholesterol
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Elevated LDL-C
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Elevated triglycerides
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Low HDL-C
Number of subjects: 1228
Study: 26655958

Group type: EXPERIMENTAL
Intervention: GBAT
Number of subjects: 35

Group type: COMPARATOR
Intervention: WL
Number of subjects: 35
Study: 25113095

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline (30 × 0.5 mg)
Number of subjects: 9
Study: 22296762

Group type: EXPERIMENTAL
Intervention: SMS messaging intervention (n=8)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (n=13)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Counting pills method (Intervention group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Counting pills method (Control group)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Microelectronic monitoring (Intervention group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Microelectronic monitoring (Control group)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Feedback from intervention group participants
Number of subjects: 21
Study: 18222552

Group type: EXPERIMENTAL
Intervention: Home-based telemanagement (HBT) program
Number of subjects: 460

Group type: COMPARATOR
Intervention: Usual care (UC) program
Number of subjects: 460
Study: 16877007

Group type: EXPERIMENTAL
Intervention: SWS
Number of subjects: 0

Group type: COMPARATOR
Intervention: REM sleep
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wakefulness
Number of subjects: 0
Study: 15101854

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis fluid infusion (2000 ml)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy control measurements by 10 EMTs
Number of subjects: 34
Study: 12236394

Group type: EXPERIMENTAL
Intervention: CAHPS report along with standard enrollment materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard enrollment materials (Control group)
Number of subjects: 0
Study: 9635370

Group type: EXPERIMENTAL
Intervention: Granulocyte colony stimulating factor (G‐CSF) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stem cell factor (SCF) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine therapy (G‐CSF and SCF)
Number of subjects: 0
Study: 7791682

Group type: EXPERIMENTAL
Intervention: Kaptopril (Zorkaptil)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2805603

Group type: EXPERIMENTAL
Intervention: High protein diet (HPD) 2.0 g/kg ideal body weight
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normal protein diet (NPD) 1 g/kg ideal body weight
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low protein diet (LPD) 0.5 g/kg ideal body weight
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High protein diet (HPD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low protein diet (LPD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal protein diet (NPD)
Number of subjects: 12
Study: 809651

Group type: EXPERIMENTAL
Intervention: Lanicor
Number of subjects: 24

Group type: COMPARATOR
Intervention: Card-Lamuran
Number of subjects: 24

Group type: COMPARATOR
Intervention: MF708d
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lanitop
Number of subjects: 24
Study: 31524836

Group type: EXPERIMENTAL
Intervention: Prehospital plasma
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control (no prehospital plasma)
Number of subjects: 626
Study: 29369454

Group type: EXPERIMENTAL
Intervention: 10-day concomitant therapy (rabeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, metronidazole 500 mg twice daily)
Number of subjects: 270

Group type: COMPARATOR
Intervention: 14-day PAM-B therapy (rabeprazole 20 mg, amoxicillin 1 g, metronidazole 750 mg, tripotassium dicitrato bismuthate 600 mg twice daily)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 270
Study: 27373556

Group type: EXPERIMENTAL
Intervention: Bushen capsule
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 60
Study: 25467540

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural self-help treatment consisting of 14 modules over 8 weeks with weekly email feedback from a clinical psychologist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group receiving treatment after 8 weeks.
Number of subjects: 0
Study: 22858557

Group type: EXPERIMENTAL
Intervention: Ty21a vaccination
Number of subjects: 35
Study: 20678240

Group type: EXPERIMENTAL
Intervention: EORTC QLQ‐C30 at baseline (T1) and after three months (T2)
Number of subjects: 239
Study: 18312060

Group type: EXPERIMENTAL
Intervention: Levetiracetam 500 mg/day to 3000 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15881484

Group type: EXPERIMENTAL
Intervention: Bedtime administration of miconazole nitrate 1200 mg vaginal ovule
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Daytime administration of miconazole nitrate 1200 mg vaginal ovule
Number of subjects: 573

Group type: COMPARATOR
Intervention: Both groups (Daytime and Bedtime)
Number of subjects: 573
Study: 12657915

Group type: EXPERIMENTAL
Intervention: Oral administration of 20 mg nefopam hydrochloride solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 20 mg nefopam hydrochloride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous administration of nefopam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral administration of nefopam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous and oral administration of nefopam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Urinary excretion of parent and metabolite enantiomers
Number of subjects: 24
Study: 10830223

Group type: EXPERIMENTAL
Intervention: Cyclosporine + Azathioprine (1 mg/kg/day)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cyclosporine monotherapy
Number of subjects: 116
Study: 8772679

Group type: EXPERIMENTAL
Intervention: Lovastatin (mean dose of 36 mg/d)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lovastatin-treated smokers
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo-treated smokers
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (smokers)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (nonsmokers)
Number of subjects: 90
Study: 1602039

Group type: EXPERIMENTAL
Intervention: XYLIHEX
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CHX
Number of subjects: 45

Group type: COMPARATOR
Intervention: NaF
Number of subjects: 45
Study: 4092636

Group type: EXPERIMENTAL
Intervention: Early contact group (experimental)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Late contact group (control)
Number of subjects: 22
Study: 30849721

Group type: COMPARATOR
Intervention: Inactive Control (IC) - benign video clip (nature scenes viewed while standing)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test for children (TSST‐C)
Number of subjects: 88
Study: 30626863

Group type: EXPERIMENTAL
Intervention: Cervical isometric exercises in addition to standard physical and speech therapy for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard physical and speech therapy only
Number of subjects: 70
Study: 26931055

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (200 mg daily) plus NAC (2000 mg daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fluvoxamine (200 mg daily) plus placebo
Number of subjects: 44
Study: 24686045

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 8 mg/2 mL with 50 mL IV normal saline
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 8 mg in 50 mL normal saline
Number of subjects: 80

Group type: COMPARATOR
Intervention: Perineural saline/2 mL with 50 mL normal saline
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 8 mg/2 mL
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IV dexamethasone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 80
Study: 22271538

Group type: EXPERIMENTAL
Intervention: Memory and Attention Adaptation Training (MAAT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist, no treatment control
Number of subjects: 40
Study: 20359769

Group type: EXPERIMENTAL
Intervention: N95 masks (1860 or 1860s or 1862; 3M, St Paul, MN, USA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Totobobo masks (Dream Lab One Pte Ltd, Singapore)
Number of subjects: 22

Group type: COMPARATOR
Intervention: N95 masks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Totobobo masks
Number of subjects: 22
Study: 18381573

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 2 mg/d subcutaneously for 8 weeks
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 2 mg/d subcutaneously for 8 weeks + Testosterone (T) 250 mg/week intramuscularly for 5 weeks
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Testosterone (T) 250 mg/week intramuscularly for 5 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 96
Study: 15772568

Group type: EXPERIMENTAL
Intervention: Ospemifene 90 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ospemifene 30 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Raloxifene 60 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All ospemifene groups
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 118
Study: 12438990

Group type: EXPERIMENTAL
Intervention: InFUSE Bone Graft with threaded cortical allograft dowels
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group with threaded allograft dowels and autogenous iliac crest bone graft
Number of subjects: 46
Study: 10343132

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Exposure to H. pylori
Number of subjects: 46
Study: 7860757

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 0.5 mU/kg-1 per min-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 1.0 mU/kg-1 per min-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin infusion (both low and high)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 0
Study: 2006767

Group type: EXPERIMENTAL
Intervention: Oral dipyridamole thallium 201 tomography
Number of subjects: 45

Group type: COMPARATOR
Intervention: Left ventriculography
Number of subjects: 45
Study: 6812687

Group type: EXPERIMENTAL
Intervention: Scarred kidneys (n=18)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Unscarred kidneys (n=30)
Number of subjects: 48
Study: 31138256

Group type: EXPERIMENTAL
Intervention: STEP‐KOA (internet-based exercise program for 3 months)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: STEP‐KOA (bi-weekly physical activity coaching calls for 3 months)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: STEP‐KOA (in-person PT visits if needed)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Arthritis Education (AE) Control group
Number of subjects: 345
Study: 29262836

Group type: EXPERIMENTAL
Intervention: Accelerated postoperative radiotherapy (7 fractions per week, 2 Gy fractions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional postoperative radiotherapy (5 fractions per week, 2 Gy fractions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment methods
Number of subjects: 0
Study: 24978062

Group type: EXPERIMENTAL
Intervention: P6 acupressure with Sea-Band
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sham group (placebo)
Number of subjects: 95
Study: 24911034

Group type: EXPERIMENTAL
Intervention: Oronasopharyngeal suction (ONPS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: No suction
Number of subjects: 170
Study: 22935569

Group type: EXPERIMENTAL
Intervention: Impella 2.5
Number of subjects: 452

Group type: COMPARATOR
Intervention: IABP
Number of subjects: 452
Study: 19684522

Group type: EXPERIMENTAL
Intervention: Outpatient oral ofloxacin 7.5 mg/kg 12 hourly and amoxycillin‐clavulanate 12.5 mg/kg 8 hourly
Number of subjects: 88

Group type: COMPARATOR
Intervention: Outpatient intravenous (IV) ceftriaxone 75 mg/kg and amikacin 15 mg/kg once daily
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both oral and IV arms
Number of subjects: 88
Study: 17471546

Group type: EXPERIMENTAL
Intervention: 12 intravenous cyclophosphamide pulses
Number of subjects: 48

Group type: COMPARATOR
Intervention: 6 intravenous cyclophosphamide pulses
Number of subjects: 48
Study: 15040503

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone 30 mg twice daily
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg plus medroxyprogesterone 30 mg twice daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: Acetazolamide 250 mg plus placebo twice daily
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone
Number of subjects: 44
Study: 11958306

Group type: EXPERIMENTAL
Intervention: Hypothermic group (NP temperature maintained at 28.0-28.5 degrees C, arterial blood temperature lowered to 25.0 degrees C, re-warmed to 38.0 degrees C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normothermic group (NP temperature maintained at 36.5-37.0 degrees C, arterial blood temperature raised to a maximum of 37.0 degrees C)
Number of subjects: 80